Loteprednol Etabonate

Especificaciones

82034-46-6Número CAS

639-474-4Número CE

chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylateNombre IUPAC

C24H31ClO7Fórmula química

466.9 g/molPeso molecular

Loteprednol etabonate; 82034-46-6; Lotemax; Alrex; HGP-1; Inveltys; CDDD-5604; P-5604; Airex; chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate; DTXSID2046468; CDDD 5604; YEH1EZ96K6; EYSUVIS; CDDD5604; CHEBI:31784; KPI-121; DTXCID0026468; chloromethyl 17alpha-[(ethoxycarbonyl)oxy]-11beta-hydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylate; Lotemax SM; chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta(a)phenanthrene-17-carboxylate; chloromethyl 17alpha-((ethoxycarbonyl)oxy)-11beta-hydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylate; CEHOAC; Etabonate, Loteprednol; RefChem:58139; Chloromethyl 17 ethoxycarbonyloxy 11 hydroxy 3 oxoandrosta 1,4 diene 17 carboxylate; chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate; Androsta-1,4-diene-17-carboxylic Acid, 17-((ethoxycarbonyl)oxy)-11-hydroxy-3-oxo-, chloromethyl Ester,(11beta,17alpha)-; 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate, Chloromethyl; C24H31ClO7; MFCD00870765; Chloromethyl 11beta,17-dihydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylate, 17-(ethyl carbonate); Loterox; Locort; (8S,9S,10R,11S,13S,14S,17R)-chloromethyl 17-((ethoxycarbonyl)oxy)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylate; Lotemax (TN); CAS-82034-46-6; UNII-YEH1EZ96K6; HGP 1; Loteprednol etabonate [USAN]; Loteflam;; Lotemax;; Alrex;; Loteprednol etabonate (JAN/USAN); NCGC00164594-01; Androsta-1,4-diene-17-carboxylic acid, 17-((ethoxycarbonyl)oxy)-11-hydroxy-3-oxo-, chloromethyl ester, (11beta,17alpha)-; Androsta-1,4-diene-17-carboxylic acid, 17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxo-, chloromethyl ester, (11beta,17alpha)-; IDR-90102; IDR-90103; Loteprednol etabonate Opphthalmic suspension; P 5604; SCHEMBL23907; MLS001424221; GTPL7085; orb1310863; orb3139799; CHEMBL1200865; DMKSVUSAATWOCU-HROMYWEYSA-N; HMS2051F16; HMS2232J09; HMS3715N06; LOTEPREDNOL ETABONATE [MI]; Loteprednol etabonate [USAN:JAN]; LOTEPREDNOL ETABONATE [JAN]; MSK10482; Tox21_112219; BDBM50248301; EBC-11210; LOTEPREDNOL ETABONATE [VANDF]; s1669; LOTEPREDNOL ETABONATE [MART.]; AKOS005145741; LOTEPREDNOL ETABONATE [WHO-DD]; Tox21_112219_1; CCG-101041; CS-0900; DB14596; FC24949; GS-3599; NC00291; Loteprednol Etabonate, >=98% (HPLC); NCGC00164594-02; NCGC00164594-07; BL300051; chloromethyl (1R,3aS,3bS,9aR,9bS,10S,11aS)-1-[(ethoxycarbonyl)oxy]-10-hydroxy-9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene-1-carboxylate; DA-75083; HY-17358; Loteprednol etabonate - Bio-X trade mark; SMR000469178; SY102911; LOTEPREDNOL ETABONATE [ORANGE BOOK]; ZYLET COMPONENT LOTEPREDNOL ETABONATE; L0327; NS00003818; D01689; AB00698349-05; AB00698349-07; AB00698349_08; EN300-19768286; Q3837481; BRD-K39983086-001-06-1; CDDD-5604, HGP-1, P-560 4, alrex, lotemax; chloromethyl (1S,2R,10S,11S,14R,15S,17S)-14-[(ethoxycarbonyl)oxy]-17-hydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-14-carboxylate; Chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-Sinónimos